These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22151745)

  • 41. The impact of substance use on brain structure in people at high risk of developing schizophrenia.
    Welch KA; McIntosh AM; Job DE; Whalley HC; Moorhead TW; Hall J; Owens DG; Lawrie SM; Johnstone EC
    Schizophr Bull; 2011 Sep; 37(5):1066-76. PubMed ID: 20223841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabis Use, Polysubstance Use, and Psychosis Spectrum Symptoms in a Community-Based Sample of U.S. Youth.
    Jones JD; Calkins ME; Scott JC; Bach EC; Gur RE
    J Adolesc Health; 2017 Jun; 60(6):653-659. PubMed ID: 28318911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substance-induced Psychosis in Youth.
    Beckmann D; Lowman KL; Nargiso J; McKowen J; Watt L; Yule AM
    Child Adolesc Psychiatr Clin N Am; 2020 Jan; 29(1):131-143. PubMed ID: 31708042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychosis and substance abuse: cause, effect or coincidence?
    Lawrie SM; Hutchison JK; Sweeney SR; Fernando MR; McAdam CA; Monsour MR; Campbell TJ; MacLeod CM
    Scott Med J; 1995 Dec; 40(6):174-6. PubMed ID: 8693334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adolescence, schizophrenia and drug abuse: a window of vulnerability.
    van Nimwegen L; de Haan L; van Beveren N; van den Brink W; Linszen D
    Acta Psychiatr Scand Suppl; 2005; (427):35-42. PubMed ID: 15877720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ketamine users have high rates of psychosis and/or depression.
    Liang HJ; Tang KL; Chan F; Ungvari GS; Tang WK
    J Addict Nurs; 2015; 26(1):8-13. PubMed ID: 25761158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deconstructing sub-clinical psychosis into latent-state and trait variables over a 30-year time span.
    Rössler W; Hengartner MP; Ajdacic-Gross V; Haker H; Angst J
    Schizophr Res; 2013 Oct; 150(1):197-204. PubMed ID: 23932663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The electroencephalogram in cannabis associated psychosis.
    Campbell DR
    Can Psychiatr Assoc J; 1971 Apr; 16(2):161-5. PubMed ID: 5559086
    [No Abstract]   [Full Text] [Related]  

  • 49. Psychoses associated with marijuana use in Thailand.
    Kroll P
    J Nerv Ment Dis; 1975 Sep; 161(3):149-56. PubMed ID: 1176971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of cannabis in psychiatric disturbance.
    Knight F
    Ann N Y Acad Sci; 1976; 282():64-71. PubMed ID: 1071395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do the Transmissible Liability Index (TLI) and Adolescent Cannabis Use Predict Paranoid and Schizotypal Symptoms at Young Adulthood?
    Sharma P; Riehm KE; Young AS; Reynolds MD; Tarter RE; Horner MS; Hammond CJ
    Subst Use Misuse; 2021; 56(13):2026-2034. PubMed ID: 34402373
    [No Abstract]   [Full Text] [Related]  

  • 52. Cannabis use and the risk of developing a psychotic disorder.
    Hall W; Degenhardt L
    World Psychiatry; 2008; 7(2):68-71. PubMed ID: 18560513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The link between schizophrenia and substance use disorder: A unifying hypothesis.
    Khokhar JY; Dwiel LL; Henricks AM; Doucette WT; Green AI
    Schizophr Res; 2018 Apr; 194():78-85. PubMed ID: 28416205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabis, stimulants and psychosis. Commentary on Gururajan et al. (2012): drugs of abuse and increased risk of psychosis development.
    Sara G
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1196-7. PubMed ID: 23212141
    [No Abstract]   [Full Text] [Related]  

  • 55. Mephentermine dependence with psychosis. A case report.
    Uday GJ; Josh UG; Bhat SM
    Br J Psychiatry; 1988 Jan; 152():129-31. PubMed ID: 3167321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychotomimetic compensation versus sensitization.
    Brouwer A; Carhart-Harris RL; Raison CL
    Pharmacol Res Perspect; 2024 Aug; 12(4):e1217. PubMed ID: 38923845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabis and Psychosis: a Critical Overview of the Relationship.
    Ksir C; Hart CL
    Curr Psychiatry Rep; 2016 Feb; 18(2):12. PubMed ID: 26781550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users.
    Di Forti M; Iyegbe C; Sallis H; Kolliakou A; Falcone MA; Paparelli A; Sirianni M; La Cascia C; Stilo SA; Marques TR; Handley R; Mondelli V; Dazzan P; Pariante C; David AS; Morgan C; Powell J; Murray RM
    Biol Psychiatry; 2012 Nov; 72(10):811-6. PubMed ID: 22831980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis.
    Galvez-Buccollini JA; Proal AC; Tomaselli V; Trachtenberg M; Coconcea C; Chun J; Manschreck T; Fleming J; Delisi LE
    Schizophr Res; 2012 Aug; 139(1-3):157-60. PubMed ID: 22727454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences.
    Tien AY; Anthony JC
    J Nerv Ment Dis; 1990 Aug; 178(8):473-80. PubMed ID: 2380692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.